Treatment to preserve sight in children with rare genetic disorder shows promise in clinical trial
A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialed by clinicians and ...
Woman, 23, is blind in one eye after parasitic eye infection from swimming in contacts
A trip to the beach has turned Brooklyn McCasland’s life upside down after she contracted a vision-threatening eye infection ...
Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative join forces to combat vision loss from diabetes
More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of ...
Business Insider19h
Ocular Therapeutix™ Appoints Namrata Saroj, OD, as Chief Business Officer
About Ocular Therapeutix, Inc. Ocular Therapeutix, Inc. is a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative ...
Ottumwa Courier1d
Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative join forces to combat vision ...
More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading ... which coincides with Diabetic Eye Disease Awareness Month, we are ...
Eye exercises to improve sight – is there any science behind them? An ophthalmologist explains why you shouldn’t buy the hype
You may have seen advertisements claiming to eliminate the need for eyeglasses through vision therapy or vision training – ...
New Atlas3d
RNA therapy an effective alternative to lifelong, painful eye injections
An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...
Interesting Engineering4d
World’s first vision-restoring stem cell treatment marks major eye care breakthrough
Three individuals with vision disabilities experienced eyesight improvements after receiving stem-cell transplants targeting ...
FierceBiotech4d
Struggling AlloVir finds new identity by merging into eye disease biotech
AlloVir has been reeling ever since a trio of phase 3 trial failures last year led the company to shed almost all of its staff. | AlloVir has been reeling after a trio of phase 3 trial failures last ...
Science Daily5d
Why some patients don't respond well to wet macular degeneration treatment
A new study explains not only why some patients with wet age-related macular degeneration (or 'wet' AMD) fail to have vision improvement with treatment, but also how an experimental drug could be used ...
Opthea Limited: Major Catalyst In Early 2025 For Complementary Eye Disease Candidate
Opthea is a clinical-stage biotech firm developing Sozinibercept, targeting VEGF-C and VEGF-D for wet AMD, with Phase 3 ...
Eye-tracking study discovers the retinal mechanisms behind visual stability
The visual perception of optical stimuli demands high performance from the brain. Every second, the eyes absorb more than 10 ...